[DPHARMA] QoQ Annualized Quarter Result on 30-Sep-2011 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-Nov-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Sep-2011 [#3]
Profit Trend
QoQ- 5.67%
YoY- 1.61%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Revenue 140,824 144,228 138,132 140,128 136,658 131,936 131,437 4.71%
PBT 35,812 35,476 34,728 35,856 34,332 31,500 35,408 0.75%
Tax -8,662 -8,644 -8,023 -8,686 -8,620 -7,804 -6,739 18.23%
NP 27,150 26,832 26,705 27,169 25,712 23,696 28,669 -3.56%
-
NP to SH 27,150 26,832 26,705 27,169 25,712 23,696 28,669 -3.56%
-
Tax Rate 24.19% 24.37% 23.10% 24.22% 25.11% 24.77% 19.03% -
Total Cost 113,674 117,396 111,427 112,958 110,946 108,240 102,768 6.96%
-
Net Worth 162,400 170,824 163,783 162,405 154,105 162,320 156,881 2.33%
Dividend
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Div 9,716 - 24,983 - 9,718 - 222 1144.77%
Div Payout % 35.79% - 93.56% - 37.80% - 0.77% -
Equity
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Net Worth 162,400 170,824 163,783 162,405 154,105 162,320 156,881 2.33%
NOSH 138,803 138,881 138,799 138,807 138,833 138,735 138,832 -0.01%
Ratio Analysis
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
NP Margin 19.28% 18.60% 19.33% 19.39% 18.81% 17.96% 21.81% -
ROE 16.72% 15.71% 16.31% 16.73% 16.68% 14.60% 18.27% -
Per Share
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 101.46 103.85 99.52 100.95 98.43 95.10 94.67 4.73%
EPS 19.56 19.32 19.24 19.57 18.52 17.08 20.65 -3.55%
DPS 7.00 0.00 18.00 0.00 7.00 0.00 0.16 1144.47%
NAPS 1.17 1.23 1.18 1.17 1.11 1.17 1.13 2.34%
Adjusted Per Share Value based on latest NOSH - 138,763
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 14.63 14.98 14.35 14.56 14.20 13.71 13.65 4.73%
EPS 2.82 2.79 2.77 2.82 2.67 2.46 2.98 -3.61%
DPS 1.01 0.00 2.60 0.00 1.01 0.00 0.02 1269.51%
NAPS 0.1687 0.1775 0.1701 0.1687 0.1601 0.1686 0.163 2.32%
Price Multiplier on Financial Quarter End Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 -
Price 2.23 2.40 2.02 2.10 2.34 2.35 2.39 -
P/RPS 2.20 2.31 2.03 2.08 2.38 2.47 2.52 -8.66%
P/EPS 11.40 12.42 10.50 10.73 12.63 13.76 11.57 -0.98%
EY 8.77 8.05 9.52 9.32 7.91 7.27 8.64 1.00%
DY 3.14 0.00 8.91 0.00 2.99 0.00 0.07 1165.39%
P/NAPS 1.91 1.95 1.71 1.79 2.11 2.01 2.12 -6.72%
Price Multiplier on Announcement Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 16/08/12 17/05/12 22/02/12 21/11/11 18/08/11 25/05/11 23/02/11 -
Price 2.38 2.38 2.12 2.10 2.22 2.57 2.45 -
P/RPS 2.35 2.29 2.13 2.08 2.26 2.70 2.59 -6.28%
P/EPS 12.17 12.32 11.02 10.73 11.99 15.05 11.86 1.73%
EY 8.22 8.12 9.08 9.32 8.34 6.65 8.43 -1.66%
DY 2.94 0.00 8.49 0.00 3.15 0.00 0.07 1111.03%
P/NAPS 2.03 1.93 1.80 1.79 2.00 2.20 2.17 -4.35%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment